Main Article Content


Obesity is one of risk factors for heart failure in both men and women. Paradoxically, recent studies have shown that high BMIs in heart failure patients were asssociated with better outcomes. This study was aimed to prove the effect of body mass index on mortality and readmission in heart failure patients in cardiovascular outpatient care unit at Dr. Soetomo Surabaya Hospital. The research design was observational analytical study. Subjects consisted of all patients with heart disease in cardiovascular outpatient care unit at Dr. Soetomo Surabaya Hospital that meet the inclusion and exclusion criteria. Through the purposive sampling, 59 patients diagnosed with heart failure were selected. Direct measurements of body weight and height were conducted in February through March 2014 to calculate the BMIs. Based on their BMIs, subjects were then placed into two categories, which were patients with normal and elevated BMIs. Information on deaths and readmissions were gathered in October 2014. The relationship between two variables were then analyzed using Fisher Exact Test. After 8 months of follow up, 5 people (8.5%) died of cardiovascular cause and 7 (11.9%) were re-admitted to the hospital. Among 28 patients with normal BMIs, 3 (10.7%) died and 3 (10.7%) were re-admitted. Among 31 patients with elevated BMIs, 2 (6.5%) died and 4 (12.9%) were re-admitted to the hospital. By using Fisher Exact Test, it was shown that there is no effect of BMI on mortality (p=0.661) and readmission (p=1.000) in heart failure patients.


body mass index heart failure mortality readmission outpatient

Article Details

How to Cite


  1. Bui AL, Horwich TB, Fonarow GC (2011). Epidemiology and risk profile of heart failure. Nature Reviews Cardiology 8, 30-41
  2. Callender T, Woodward M, Roth G, Farzadfar F, Lemarie JC, Gicquel S, Atherton J, Rahimzadeh S, Ghaziani M, Shaikh M, Bennett D, Patel A, Lam CSP, Sliwa K, Barretto A, Siswanto BB, Diaz A, Herpin D, Krum H, Eliasz T, Forbes A, Kiszely A, Khosla R, Petrinic T, Praveen D, Shrivastava R, Xin D, MacMahon S, McMurray J, Rahimi K (2014). Heart failure care in low-and middle-income countries: a systematic review and meta-analysis. PLoS Medicine 11, e1001699
  3. Curtis JP, Selter JG, Wang Y, Rathore SS, Jovin IS, Jadbabaie F, Kosiborod M, Portnay EL, Sokol SI, Bader F, Krumholz HM (2005). The obesity paradox: body mass index and outcomes in patients with heart failure. Archives of Internal Medicine 165, 55-61
  4. Fitzgibbons TP, Hardy OT, Lessard D, Gore JM, Yarzebski J, Goldberg RJ (2009). Body mass index, treatment practices, and mortality in patients with acute heart failure. Coronary Artery Disease 20, 536-543
  5. Gruberg L, Weissman NJ, Waksman R, Fuchs S, Deible R, Pinnow EE, Ahmed LM, Kent KM, Pichard AD, Suddath WO, Satler LF, Lindsay J Jr (2002). The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? J Am Colle Cardiol 39, 578-584
  6. Haass M, Kitzman DW, Anand IS, Miller A, Zile MR, Massie BM, Carson PE (2011). Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial. Circulation Heart Failure 4, 324-331
  7. He J, Ogden LG, Bazzano LA, Vupputuri S, Loria C, Whelton PK (2001). Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Archives of Internal Medicine 161, 996-1002
  8. Joseph SM, Cedars AM, Ewald GA, Geltman EM, Mann DL (2009). Acute decompensated heart failure: contemporary medical management. Texas Heart Institute Journal 36, 510-520
  9. Kenchaiah S, Evans JC, Levy D, Wilson PWF, Benjamin EJ, Larson MG, Kannel WB, Vasan RS (2002). Obesity and the risk of heart failure. N Engl J Med 347, 305-313
  10. Kenchaiah S, Pocock SJ, Wang D, Finn PV, Zornoff LA, Skali H, Pfeffer MA, Yusuf S, Swedberg K, Michelson EL, Granger CB, McMurray JJ, Solomon SD; CHARM Investigators (2007). Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation 116, 627-636
  11. Oreopoulos A, Padwal R, Kalantar-Zadeh K, Fonarow GC, Norris CM, McAlister FA (2008). Body mass index and mortality in heart failure: a meta-analysis. Am Heart J 156, 13-22
  12. Siswanto BB, Radi B, Kalim H, Santoso A, Suryawan R, Erwinanto, Antono E, Santoso T (2010). Heart failure in NCVC Jakarta and 5 hospitals in Indonesia. CVD Prevention and Control 5, 35-38
  13. WHO (2008). The Global Burden of Disease 2004 Update. Geneva: WHO Press
  14. Zamora E, Lupón J, Urrutia A, González B, Mas D, Pascual T, Domingo M, Valle V (2007). Does body mass index influence mortality in patients with heart failure? Rev Esp Cardiol 60, 1127-1134